FBIO - Fortress Biotech, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Fortress Biotech, Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
IPO Date: December 1, 2011
Sector: Healthcare
Industry: Biotech
Market Cap: $68.04M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.10 | 4.31%
Avg Daily Range (30 D): $0.05 | 1.88%
Avg Daily Range (90 D): $0.09 | 3.23%
Institutional Daily Volume
Avg Daily Volume: .46M
Avg Daily Volume (30 D): .28M
Avg Daily Volume (90 D): .48M
Trade Size
Avg Trade Size (Sh.): 222
Avg Trade Size (Sh.) (30 D): 150
Avg Trade Size (Sh.) (90 D): 147
Institutional Trades
Total Institutional Trades: 38
Avg Institutional Trade: $2.32M
Avg Institutional Trade (30 D): $.5M
Avg Institutional Trade (90 D): $.5M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.49M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 11.5K
 
News
Sep 8, 2026 @ 12:00 PM
Fortress Biotech to Present at the H.C. Wainwright...
Source: Na
Oct 1, 2025 @ 7:45 PM
Fortress Biotech Investigated by the Portnoy Law F...
Source: Lesley F. Portnoy
Oct 1, 2025 @ 12:00 PM
Fortress Biotech and Cyprium Therapeutics Annou...
Source: Fortress Biotech, Inc.
May 30, 2025 @ 2:47 PM
Fortress Biotech Announces Closing of Sale of Subs...
Source: Globe Newswire
May 7, 2025 @ 12:00 PM
Fortress Biotech to Participate in the H.C. Wainwr...
Source: N/A
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $3.26 $-.08 $3.44
Diluted EPS $2.64 $-.08 $2.82
Revenue $68.47M $18.72M $16.04M
Gross Profit $44.91M $12.58M $9.82M
Net Income / Loss $141.19M $.6M $137.16M
Operating Income / Loss $-29.35M $-10.01M $-7.74M
Cost of Revenue $23.56M $6.14M $6.22M
Net Cash Flow $122.19M $117.2M $M
PE Ratio    
Splits
Oct 10, 2023 1:15
Dec 06, 2022 1:10